A Unique Roadblock for Pfizer’s Osteoarthritis Drug
We’ve heard of drugs underperforming in clinical trials, but is it possible for a drug to over-perform?
We’ve heard of drugs underperforming in clinical trials, but is it possible for a drug to over-perform?
On 10/19/09, BioElectronics (OTC: BIEL.PK) announced the initial results from the pilot section of its ongoing acetaminophen comparison study.
Copyright © 2024 | WordPress Theme by MH Themes